pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 766 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    MTI-201
    Metastatic Uveal Melanoma Modulation Therapeutics Inc
  • Phase 1
    MuSK-CAART
    Myasthenia Gravis$CABA Cabaletta Bio, Inc.
  • Phase 1
    MyoPAXon
    Duchenne Muscular Dystrophy Myogenica Inc
  • Phase 1
← prev
page 15 of 26
next →
131
Pain89
Neurology1
NA-731
Traumatic Brain Injury
Biomed Industries Inc
  • Phase 1
    NAS-150
    Idiopathic Pulmonary Fibrosis New Amsterdam Sciences Inc
  • Phase 1
    NC-2400
    Dyslipidemia ABIONYX Pharma SA
  • Phase 1
    NIM-1324
    Rheumatoid Arthritis NImmune Biopharma Inc
  • Phase 1
    NKT-3964
    Adenocarcinoma Of The Gastroesophageal Junction NiKang Therapeutics Inc
  • Phase 1
    NLX-101
    Fragile X Syndrome Neurolixis Inc
  • Phase 1
    NM-5072
    Paroxysmal Nocturnal Hemoglobinuria NovelMed Therapeutics Inc
  • Phase 1
    NM-6603
    Colorectal Cancer Nucmito
  • Phase 1
    NMS-812
    Refractory Acute Myeloid Leukemia Nerviano Medical Sciences SRL
  • Phase 1
    NN-3201
    Adenoid Cystic Carcinoma (ACC) Novelty Nobility Inc
  • Phase 1
    NNI-362
    Alzheimer's Disease NeuroNascent Inc
  • Phase 1
    NO-13065
    Obesity Otsuka Pharmaceutical Co Ltd
  • Phase 1
    NOVA-1010
    Schizophrenia Novastage Pharmaceuticals (Shenzhen) Ltd
  • Phase 1
    NP-10679
    Subarachnoid Hemorrhage NeurOp Inc
  • Phase 1
    NP-3
    Nephropathic Cystinosis Nacuity Pharmaceuticals Inc
  • Phase 1
    NPX-887
    Adenocarcinoma Of The Gastroesophageal Junction NextPoint Therapeutics Inc
  • Phase 1
    NRL-1049
    Cavernous Hemangioma (Cerebral Cavernous Malformation/Cer… Neurelis Inc
  • Phase 1
    NRS-033
    Opium (Opioid) Addiction Nirsum Laboratories Inc
  • Phase 1
    NTP-42
    Pulmonary Arterial Hypertension ATXA Therapeutics Ltd
  • Phase 1
    NTS-1104
    Acute Ischemic Stroke NeuroTrauma Sciences LLC
  • Phase 1
    NVK-029
    Presbyopia Vyluma Inc
  • Phase 1
    NVK-031
    Unspecified Ophthalmological Disorders Vyluma Inc
  • Phase 1
    NX-1607
    Adenocarcinoma Of The Gastroesophageal Junction$NRIX Nurix Therapeutics, Inc.
  • Phase 1
    NXP-900
    Cervical Cancer$NVCT Nuvectis Pharma, Inc.
  • Phase 1
    Nezavist
    Alcohol Use Disorder (AUD) Lohocla Research Corp
  • Phase 1
    OCF-001
    Vulvovaginal Candidiasis Sano Chemicals Inc
  • Phase 1
    OCU-200
    Diabetic Macular Edema$OCGN Ocugen, Inc.